Radiation therapy for histologically confirmed primary central nervous system germinoma

被引:84
作者
Haddock, MG
Schild, SE
Scheithauer, BW
Schomberg, PJ
机构
[1] MAYO CLIN & MAYO FDN,DEPT PATHOL & LAB MED,ROCHESTER,MN 55905
[2] MAYO CLIN,DIV RADIAT ONCOL,SCOTTSDALE,AZ
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1997年 / 38卷 / 05期
关键词
germinoma; pineal tumors; suprasellar tumors; radiotherapy; prognosis;
D O I
10.1016/S0360-3016(97)00135-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate survival and patterns of recurrence in patients with primary central nervous system germinoma treated with radiation therapy, Methods and Materials: Data regarding 48 patients with histologically confirmed, primary central nervous system germinoma were reviewed, All had been operated on at the Mayo Clinic between the years 1935 and 1993, Thirty-two patients (67%) were treated since 1973, The study group included 39 males and 9 females, with a median age at diagnosis of 17 years (range, 6-42 years), Twelve patients (25%) were treated with craniospinal axis irradiation, 11 (23%) received whole-brain irradiation without spinal axis irradiation, and 24 (50%) underwent partial-brain irradiation. Treatment volumes were unknown in one patient. The median dose to the primary tumor was 44.00 Gy (range, 7.44-59.40 Gy), The median follow-up was 5.5 years (range, 4 months to 37 years). Results: Actuarial 5-year and 10-year survival for the entire study group of patients was 80%, There was a trend toward improved survival in patients treated after 1973 (introduction of computed tomography) with 5-year and 10-year survival of 91% vs. 63% in prior years (p = 0.07). For the group of 31 patients treated since 1973 with known treatment volumes, the spinal axis failure rate at 5 years was 49% for patients treated with partial brain fields (11 patients) vs, 0% for those having undergone whole brain (10 patients) or craniospinal axis (10 patients) irradiation (p = 0.007), The rate of brain failure was also significantly higher in patients receiving less than whole-brain irradiation; at 5 years, 45% of the patients treated with partial-brain fields had intracranial recurrence of disease compared to 6% of patients treated with craniospinal axis or whole-brain irradiation (p = 0.01), Among the 32 modern era patients, the rate of brain failure was higher in patients who received doses less than 40 Gy (median dose, 48.55 Gy; range, 30.60-59.40 Gy) to the primary tumor (5-year brain failure rate 52% vs, 11%, p = 0.002), Conclusion: The long-term survival of patients with histologically proven CNS germinoma treated with radiation is excellent, Whole-brain or craniospinal axis irradiation appears to result in fewer spine and brain failures than does partial-brain irradiation, Furthermore, the administration of doses greater than 40 Gy to the primary tumor is associated with better local control. (C) 1997 Elsevier Science Inc.
引用
收藏
页码:915 / 923
页数:9
相关论文
共 47 条
  • [31] PATEL SR, 1992, J NEURO-ONCOL, V12, P47
  • [32] ASYMPTOTICALLY EFFICIENT RANK INVARIANT TEST PROCEDURES
    PETO, R
    PETO, J
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES A-GENERAL, 1972, 135 : 185 - &
  • [33] RAO YTR, 1981, CANCER, V48, P708, DOI 10.1002/1097-0142(19810801)48:3<708::AID-CNCR2820480308>3.0.CO
  • [34] 2-S
  • [35] RICH TA, 1985, CANCER, V55, P932, DOI 10.1002/1097-0142(19850301)55:5<932::AID-CNCR2820550504>3.0.CO
  • [36] 2-H
  • [37] DIAGNOSIS AND TREATMENT OF TUMORS IN PINEAL REGION
    SANO, K
    [J]. ACTA NEUROCHIRURGICA, 1976, 34 (1-4) : 153 - 157
  • [38] SANO K, 1981, CHILD BRAIN, V8, P81
  • [39] TREATMENT RESULTS OF INTRACRANIAL GERMINOMA AS A FUNCTION OF THE IRRADIATED VOLUME
    SHIBAMOTO, Y
    ABE, M
    YAMASHITA, J
    TAKAHASHI, M
    HIRAOKA, M
    ONO, K
    TSUTSUI, K
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1988, 15 (02): : 285 - 290
  • [40] WHOLE-BRAIN IRRADIATION AND DECLINE IN INTELLIGENCE - THE INFLUENCE OF DOSE AND AGE ON IQ SCORE
    SILBER, JH
    RADCLIFFE, J
    PECKHAM, V
    PERILONGO, G
    KISHNANI, P
    FRIDMAN, M
    GOLDWEIN, JW
    MEADOWS, AT
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (09) : 1390 - 1396